Literature DB >> 26525995

Trajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment.

Nicholas D David1, Feng Lin2, Anton P Porsteinsson3.   

Abstract

OBJECTIVE: To characterize the course of neuropsychiatric symptoms (NPS) in adults with mild cognitive impairment (MCI), and to examine baseline individual-level predictors and associated cognitive and functional outcomes.
DESIGN: A 2-year prospective cohort study.
SETTING: Multicenter clinical settings. PARTICIPANTS: Five hundred sixty individuals with MCI at baseline. MEASUREMENTS: NPS severity (measured using Neuropsychiatric Inventory Questionnaire) and cognitive and functional outcomes were assessed at baseline and every 6 months thereafter. Potential individual-level predictors were collected at baseline.
RESULTS: Three latent classes of NPS courses were identified using growth mixture modeling: a stable class in which a low NPS burden remained relatively unchanged over time (N = 503, 89.8%); a worsened class in which an initially moderate NPS burden increased (N = 39, 7.0%); and an improved class in which an initially high NPS burden decreased (N = 18, 3.2%). There were no associations between class membership and baseline individual characteristics. Members of the worsened class were 1.74 times more likely to be diagnosed with incident Alzheimer disease (AD) than members of the stable class (95% confidence interval: 1.07-2.84). The worsened class also showed significantly more rapid declines in cognitive and functional outcomes than the stable class. Class membership did not predict rate of brain atrophy.
CONCLUSIONS: Patients with MCI may experience different trajectories of NPS over time. Patients with worsening NPS may be at greater risk of developing AD and severe cognitive and functional impairment.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neuropsychiatric symptoms; latent class analysis; mild cognitive impairment

Mesh:

Year:  2015        PMID: 26525995      PMCID: PMC4691566          DOI: 10.1016/j.jagp.2015.06.001

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  40 in total

1.  A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

Authors:  Laura E Gibbons; Adam C Carle; R Scott Mackin; Danielle Harvey; Shubhabrata Mukherjee; Philip Insel; S McKay Curtis; Dan Mungas; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study.

Authors:  Pauline Aalten; Marjolein E de Vugt; Niek Jaspers; Jaspers Jolles; Frans R J Verhey
Journal:  Int J Geriatr Psychiatry       Date:  2005-06       Impact factor: 3.485

3.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian S Appleby; Esther S Oh; Yonas E Geda; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

4.  Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.

Authors:  M E Peters; P B Rosenberg; M Steinberg; M C Norton; K A Welsh-Bohmer; K M Hayden; J Breitner; J T Tschanz; C G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

5.  The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.

Authors:  Kate de Medeiros; P Robert; S Gauthier; F Stella; A Politis; J Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; J Cummings; C Lyketsos
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

Review 6.  Neuropsychiatric symptoms in the prodromal stages of dementia.

Authors:  Florindo Stella; Márcia Radanovic; Márcio L F Balthazar; Paulo R Canineu; Leonardo C de Souza; Orestes V Forlenza
Journal:  Curr Opin Psychiatry       Date:  2014-05       Impact factor: 4.741

7.  Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period.

Authors:  Roland B Wetzels; Sytse U Zuidema; Jos F M de Jonghe; Frans R J Verhey; Raymond T C M Koopmans
Journal:  Am J Geriatr Psychiatry       Date:  2010-12       Impact factor: 4.105

8.  Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers.

Authors:  Kyle Steenland; Conny Karnes; Ryan Seals; Claudine Carnevale; Adriana Hermida; Allan Levey
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

9.  Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia.

Authors:  Emily R Edwards; Adam P Spira; Deborah E Barnes; Kristine Yaffe
Journal:  Int J Geriatr Psychiatry       Date:  2009-07       Impact factor: 3.485

10.  Predictors of progression from mild cognitive impairment to Alzheimer disease.

Authors:  K Palmer; A K Berger; R Monastero; B Winblad; L Bäckman; L Fratiglioni
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

View more
  11 in total

Review 1.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

2.  Identify a shared neural circuit linking multiple neuropsychiatric symptoms with Alzheimer's pathology.

Authors:  Xixi Wang; Ping Ren; Mark Mapstone; Yeates Conwell; Anton P Porsteinsson; John J Foxe; Rajeev D S Raizada; Feng Lin
Journal:  Brain Imaging Behav       Date:  2019-02       Impact factor: 3.978

3.  Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia.

Authors:  Jeannie-Marie S Leoutsakos; Elizabeth A Wise; Constantine G Lyketsos; Gwenn S Smith
Journal:  Int J Geriatr Psychiatry       Date:  2019-09-02       Impact factor: 3.485

4.  Measuring emotion recognition: Added value in diagnosing dementia of the Alzheimer's disease type.

Authors:  Fijanne Strijkert; Rients Bauke Huitema; Jacoba Margje Spikman
Journal:  J Neuropsychol       Date:  2021-10-18       Impact factor: 2.276

5.  Cerebral Amyloid Angiopathy Is Associated With Emotional Dysregulation, Impulse Dyscontrol, and Apathy.

Authors:  Eric E Smith; Stephanie Crites; Meng Wang; Anna Charlton; Angela Zwiers; Ramnik Sekhon; Tolulope Sajobi; Richard Camicioli; Cheryl R McCreary; Richard Frayne; Zahinoor Ismail
Journal:  J Am Heart Assoc       Date:  2021-11-10       Impact factor: 5.501

6.  Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.

Authors:  Willem S Eikelboom; Esther van den Berg; Ellen H Singleton; Sara J Baart; Michiel Coesmans; Annebet E Leeuwis; Charlotte E Teunissen; Bart N M van Berckel; Yolande A L Pijnenburg; Philip Scheltens; Wiesje M van der Flier; Rik Ossenkoppele; Janne M Papma
Journal:  Neurology       Date:  2021-08-19       Impact factor: 9.910

7.  Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer's disease dementia.

Authors:  Leonie C P Banning; Inez H G B Ramakers; Paul B Rosenberg; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2020-09-11       Impact factor: 3.485

Review 8.  Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease.

Authors:  Jianjun Jia; Jun Xu; Jun Liu; Yongjun Wang; Yanjiang Wang; Yunpeng Cao; Qihao Guo; Qiuming Qu; Cuibai Wei; Wenshi Wei; Junjian Zhang; Enyan Yu
Journal:  Neurosci Bull       Date:  2021-05-29       Impact factor: 5.203

9.  Prediction Models of Cognitive Trajectories in Patients with Nonamnestic Mild Cognitive Impairment.

Authors:  Jin San Lee; Seong-Kyung Cho; Hee Jin Kim; Yeo Jin Kim; Key-Chung Park; Samuel N Lockhart; Duk L Na; Changsoo Kim; Sang Won Seo
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

10.  Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment.

Authors:  Natalia Roberto; Maria J Portella; Marta Marquié; Montserrat Alegret; Isabel Hernández; Ana Mauleón; Maitee Rosende-Roca; Carla Abdelnour; Ester Esteban de Antonio; Juan P Tartari; Liliana Vargas; Rogelio López-Cuevas; Urszula Bojaryn; Ana Espinosa; Gemma Ortega; Alba Pérez-Cordón; Ángela Sanabria; Adelina Orellana; Itziar de Rojas; Sonia Moreno-Grau; Laura Montrreal; Emilio Alarcón-Martín; Agustín Ruíz; Lluís Tárraga; Mercè Boada; Sergi Valero
Journal:  Front Aging Neurosci       Date:  2021-12-08       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.